Zentalis Pharmaceuticals, Inc. (ZNTL)

Zentalis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	41.32	28.04	43.07	59.71	54.95	67.25
Short-Term Investments	349.93	454.88	394.3	280.17	283.55	-
Cash & Short-Term Investments	391.25	482.92	437.37	339.89	338.51	67.25
Cash Growth	-24.27%	10.41%	28.68%	0.41%	403.38%	167.34%
Other Receivables	-	-	-	-	0.42	0.14
Receivables	-	-	-	-	0.42	0.14
Prepaid Expenses	9.02	13.8	14.56	10.64	6.18	1.51
Restricted Cash	-	-	-	0.24	-	-
Total Current Assets	400.27	496.72	451.93	350.77	345.1	68.89
Property, Plant & Equipment	38.42	41.74	50.08	52.84	3.62	2.84
Long-Term Investments	-	-	21.21	37.5	-	-
Goodwill	3.74	3.74	3.74	3.74	3.74	3.74
Other Intangible Assets	-	-	-	-	8.8	8.8
Long-Term Deferred Charges	-	-	-	-	-	0.84
Other Long-Term Assets	8.24	9.5	12.35	9.67	4.3	2.38
Total Assets	450.66	551.69	539.31	454.51	365.56	87.48
Accounts Payable	8.2	14.93	11.25	11.59	8.66	4.29
Accrued Expenses	43.71	51.54	42.85	29.93	18.63	9.83
Current Portion of Leases	2.81	2.62	2.16	1.45	0.9	0.78
Current Income Taxes Payable	0.15	0.28	0.38	0.97	0.41	-
Total Current Liabilities	54.88	69.37	56.65	43.94	28.6	14.9
Long-Term Leases	40.46	43.15	45.17	44.46	1.1	-
Long-Term Deferred Tax Liabilities	-	-	0.85	1.62	2.48	2.46
Other Long-Term Liabilities	1	1.78	2.62	-	-	1.7
Total Liabilities	96.33	114.3	105.29	90.03	32.18	19.06
Common Stock	0.07	0.07	0.06	0.05	0.04	2.89
Additional Paid-In Capital	1,360	1,324	1,031	723.59	509.34	-
Retained Earnings	-1,007	-888.56	-596.37	-359.56	-200.83	-82.99
Comprehensive Income & Other	1.59	2.19	-1.35	-0.13	0.04	-
Total Common Equity	354.33	437.28	433.8	363.95	308.58	-80.11
Minority Interest	-	0.11	0.22	0.53	24.8	6.82
Shareholders' Equity	354.33	437.39	434.02	364.48	333.38	68.42
Total Liabilities & Equity	450.66	551.69	539.31	454.51	365.56	87.48
Total Debt	43.27	45.77	47.33	45.91	2	0.78
Net Cash (Debt)	347.99	437.15	390.04	293.98	336.51	66.47
Net Cash Growth	-26.11%	12.08%	32.68%	-12.64%	406.29%	164.23%
Net Cash Per Share	4.90	6.68	7.38	6.89	11.97	11.88
Filing Date Shares Outstanding	71.27	70.96	59.42	45.56	41.04	5.6
Total Common Shares Outstanding	71.15	70.77	59.28	45.49	41.04	5.6
Working Capital	345.39	427.35	395.29	306.83	316.5	53.99
Book Value Per Share	4.98	6.18	7.32	8.00	7.52	-14.30
Tangible Book Value	350.6	433.55	430.07	360.22	296.05	-92.64
Tangible Book Value Per Share	4.93	6.13	7.25	7.92	7.21	-16.54
Machinery	4.81	4.56	4.84	4.39	0.95	0.64
Construction In Progress	-	0.17	0.04	0.03	0.35	-
Leasehold Improvements	4.17	4.24	4.89	4.52	0.05	0.02

Source: S&P Capital IQ. Standard template. Financial Sources.